Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9035
|
pubmed:dateCreated |
1996-12-3
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
26
|
pubmed:volume |
348
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1176-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8888202-Adolescent,
pubmed-meshheading:8888202-Chemistry, Pharmaceutical,
pubmed-meshheading:8888202-Cyclosporine,
pubmed-meshheading:8888202-Graft Rejection,
pubmed-meshheading:8888202-Humans,
pubmed-meshheading:8888202-Immunosuppressive Agents,
pubmed-meshheading:8888202-Kidney Transplantation
|
pubmed:year |
1996
|
pubmed:articleTitle |
Which cyclosporin formulation?
|
pubmed:publicationType |
Letter,
Comment
|